{"id":55761,"date":"2023-04-12T23:06:21","date_gmt":"2023-04-12T21:06:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/"},"modified":"2023-04-12T23:06:21","modified_gmt":"2023-04-12T21:06:21","slug":"geron-to-present-at-upcoming-investor-conferences-in-april","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/","title":{"rendered":"Geron to Present at Upcoming Investor Conferences in April"},"content":{"rendered":"<div>\n<p>FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/5\/Geron_Full_Logo_RGB-01.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>22<sup>nd<\/sup> Annual Needham Virtual Healthcare Conference<br \/>\n<br \/><\/b>Thursday, April 20 at 10:15 a.m. ET<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Stifel 2023 Virtual Targeted Oncology Days<br \/>\n<br \/><\/b>Tuesday, April 25 at 2:00 p.m. ET<\/li>\n<\/ul>\n<p>\nA webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron\u2019s website under <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.geron.com%2Finvestors%2Fevents%2Fdefault.aspx&amp;esheet=53380216&amp;newsitemid=20230412005663&amp;lan=en-US&amp;anchor=Events&amp;index=1&amp;md5=d5b5876ab0c6869334ed790ad84d8f8b\" rel=\"nofollow noopener\" shape=\"rect\">Events<\/a>. Following each scheduled conference event, the related webcast will be archived and available for replay for a period of 30 days.<\/p>\n<p>\n<b>About Geron<\/b><\/p>\n<p>\nGeron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.geron.com%2F&amp;esheet=53380216&amp;newsitemid=20230412005663&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.geron.com%2F&amp;index=2&amp;md5=f6e5b7420ecb19bb39cbc8446f56505d\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/www.geron.com\/<\/a>or follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F163982%2Fadmin%2F&amp;esheet=53380216&amp;newsitemid=20230412005663&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=bbc4f1770fea44ee515363a5d7359f0d\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAron Feingold<br \/>\n<br \/>Investor and Media Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#105;&#x6e;v&#101;&#x73;t&#111;&#x72;&#x40;&#103;&#x65;&#x72;o&#110;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">i&#110;&#x76;&#x65;&#x73;t&#111;&#x72;&#x40;&#x67;e&#114;&#x6f;&#x6e;&#x2e;c&#111;&#x6d;<\/a><br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#109;&#x65;&#100;&#x69;&#97;&#x40;g&#x65;r&#111;&#x6e;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x65;&#x64;&#x69;&#x61;&#x40;&#x67;&#x65;&#x72;&#x6f;&#x6e;&#46;&#99;&#111;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences: 22nd Annual Needham Virtual Healthcare Conference Thursday, April 20 at 10:15 a.m. ET Stifel 2023 Virtual Targeted Oncology Days &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55761","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Geron to Present at Upcoming Investor Conferences in April - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron to Present at Upcoming Investor Conferences in April - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences: 22nd Annual Needham Virtual Healthcare Conference Thursday, April 20 at 10:15 a.m. ET Stifel 2023 Virtual Targeted Oncology Days ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T21:06:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Geron to Present at Upcoming Investor Conferences in April\",\"datePublished\":\"2023-04-12T21:06:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\"},\"wordCount\":190,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005663\\\/en\\\/1626764\\\/21\\\/Geron_Full_Logo_RGB-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\",\"name\":\"Geron to Present at Upcoming Investor Conferences in April - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005663\\\/en\\\/1626764\\\/21\\\/Geron_Full_Logo_RGB-01.jpg\",\"datePublished\":\"2023-04-12T21:06:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005663\\\/en\\\/1626764\\\/21\\\/Geron_Full_Logo_RGB-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005663\\\/en\\\/1626764\\\/21\\\/Geron_Full_Logo_RGB-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-present-at-upcoming-investor-conferences-in-april\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron to Present at Upcoming Investor Conferences in April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geron to Present at Upcoming Investor Conferences in April - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/","og_locale":"en_US","og_type":"article","og_title":"Geron to Present at Upcoming Investor Conferences in April - Pharma Trend","og_description":"FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, is scheduled to participate in fireside chats at following investor conferences: 22nd Annual Needham Virtual Healthcare Conference Thursday, April 20 at 10:15 a.m. ET Stifel 2023 Virtual Targeted Oncology Days ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-12T21:06:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Geron to Present at Upcoming Investor Conferences in April","datePublished":"2023-04-12T21:06:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/"},"wordCount":190,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/","url":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/","name":"Geron to Present at Upcoming Investor Conferences in April - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg","datePublished":"2023-04-12T21:06:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230412005663\/en\/1626764\/21\/Geron_Full_Logo_RGB-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/geron-to-present-at-upcoming-investor-conferences-in-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Geron to Present at Upcoming Investor Conferences in April"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55761"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55761\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}